Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00051611.xml
Download PDF
CC BY-NC 4.0 · Arch Plast Surg 2013; 40(06): 666-675
DOI: 10.5999/aps.2013.40.6.666
DOI: 10.5999/aps.2013.40.6.666
Review Article
Stem Cells in Plastic Surgery: A Review of Current Clinical and Translational Applications
Authors
Background Stem cells are a unique cell population characterized by self-renewal and cellular differentiation capabilities. These characteristics, among other traits, make them an attractive option for regenerative treatments of tissues defects and for aesthetic procedures in plastic surgery. As research regarding the isolation, culture and behavior of stem cells has progressed, stem cells, particularly adult stem cells, have shown promising results in both translational and clinical applications.
Methods The purpose of this review is to evaluate the applications of stem cells in the plastic surgery literature, with particular focus on the advances and limitations of current stem cell therapies. Different key areas amenable to stem cell therapy are addressed in the literature review; these include regeneration of soft tissue, bone, cartilage, and peripheral nerves, as well as wound healing and skin aging.
Results The reviewed studies demonstrate promising results, with favorable outcomes and minimal complications in the cited cases. In particular, adipose tissue derived stem cell (ADSC) transplants appear to provide effective treatment options for bony and soft tissue defects, and non-healing wounds. ADSCs have also been shown to be useful in aesthetic surgery.
Conclusions Further studies involving both the basic and clinical science aspects of stem cell therapies are warranted. In particular, the mechanism of action of stem cells, their interactions with the surrounding microenvironment and their long-term fate require further elucidation. Larger randomized trials are also necessary to demonstrate the continued safety of transplanted stem cells as well as the efficacy of cellular therapies in comparison to the current standards of care.
Publication History
Received: 22 September 2013
Accepted: 25 September 2013
Article published online:
01 May 2022
© 2013. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
REFERENCES
- 1 Walia B, Satija N, Tripathi RP. et al. Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine. Stem Cell Rev 2012; 8: 100-115
- 2 Thomson JA, Itskovitz-Eldor J, Shapiro SS. et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147
- 3 Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 2011; 11: 268-277
- 4 Swijnenburg RJ, Schrepfer S, Govaert JA. et al. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci U S A 2008; 105: 12991-12996
- 5 Al-Nbaheen M, Vishnubalaji R, Ali D. et al. Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem Cell Rev 2013; 9: 32-43
- 6 Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676
- 7 Lowry WE, Richter L, Yachechko R. et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 2008; 105: 2883-2888
- 8 Hanna J, Markoulaki S, Schorderet P. et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008; 133: 250-264
- 9 Aasen T, Raya A, Barrero MJ. et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008; 26: 1276-1284
- 10 Takenaka C, Nishishita N, Takada N. et al. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53. Exp Hematol 2010; 38: 154-162
- 11 Phanthong P, Raveh-Amit H, Li T. et al. Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells. Biogerontology. 2013
- 12 Gonzalez F, Barragan Monasterio M, Tiscornia G. et al. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci U S A 2009; 106: 8918-8922
- 13 Okita K, Nakagawa M, Hyenjong H. et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322: 949-953
- 14 Steinemann D, Gohring G, Schlegelberger B. Genetic instability of modified stem cells-a first step towards malignant transformation?. Am J Stem Cells 2013; 2: 39-51
- 15 Mayshar Y, Ben-David U, Lavon N. et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010; 7: 521-531
- 16 Zuk PA, Zhu M, Ashjian P. et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-4295
- 17 di Summa PG, Kalbermatten DF, Pralong E. et al. Long-term in vivo regeneration of peripheral nerves through bioengineered nerve grafts. Neuroscience 2011; 181: 278-291
- 18 Higuchi A, Chuang CW, Ling QD. et al. Differentiation ability of adipose-derived stem cells separated from adipose tissue by a membrane filtration method. J Memb Sci 2011; 366: 286-294
- 19 Gimble JM, Guilak F, Bunnell BA. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 2010; 1: 19
- 20 Strem BM, Hicok KC, Zhu M. et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 2005; 54: 132-141
- 21 Zuk PA, Zhu M, Mizuno H. et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211-228
- 22 Brayfield C, Marra K, Rubin JP. Adipose stem cells for soft tissue regeneration. Handchir Mikrochir Plast Chir 2010; 42: 124-128
- 23 Gir P, Oni G, Brown SA. et al. Human adipose stem cells: current clinical applications. Plast Reconstr Surg 2012; 129: 1277-1290
- 24 Eremia S, Newman N. Long-term follow-up after autologous fat grafting: analysis of results from 116 patients followed at least 12 months after receiving the last of a minimum of two treatments. Dermatol Surg 2000; 26: 1150-1158
- 25 Gir P, Brown SA, Oni G. et al. Fat grafting: evidence-based review on autologous fat harvesting, processing, reinjection, and storage. Plast Reconstr Surg 2012; 130: 249-258
- 26 Brown SA, Levi B, Lequeux C. et al. Basic science review on adipose tissue for clinicians. Plast Reconstr Surg 2010; 126: 1936-1946
- 27 Salgado AJ, Reis RL, Sousa NJ. et al. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 2010; 5: 103-110
- 28 Sheng L, Yang M, Li H. et al. Transplantation of adipose stromal cells promotes neovascularization of random skin flaps. Tohoku J Exp Med 2011; 224: 229-234
- 29 Cherubino M, Marra KG. Adipose-derived stem cells for soft tissue reconstruction. Regen Med 2009; 4: 109-117
- 30 Sommer B, Sattler G. Current concepts of fat graft survival: histology of aspirated adipose tissue and review of the literature. Dermatol Surg 2000; 26: 1159-1166
- 31 Matsumoto D, Sato K, Gonda K. et al. Cell-assisted lipotransfer: supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection. Tissue Eng 2006; 12: 3375-3382
- 32 Yoshimura K, Sato K, Aoi N. et al. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg 2008; 32: 48-55
- 33 Kamakura T, Ito K. Autologous cell-enriched fat grafting for breast augmentation. Aesthetic Plast Surg 2011; 35: 1022-1030
- 34 Wang L, Lu Y, Luo X. et al. Cell-assisted lipotransfer for breast augmentation: a report of 18 patients. Zhonghua Zheng Xing Wai Ke Za Zhi 2012; 28: 1-6
- 35 Yoshimura K, Asano Y, Aoi N. et al. Progenitor-enriched adipose tissue transplantation as rescue for breast implant complications. Breast J 2010; 16: 169-175
- 36 Yoshimura K, Sato K, Aoi N. et al. Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adipose-derived stem cells. Dermatol Surg 2008; 34: 1178-1185
- 37 Castro-Govea Y, De La Garza-Pineda O, Lara-Arias J. et al. Cell-assisted lipotransfer for the treatment of parry-romberg syndrome. Arch Plast Surg 2012; 39: 659-662
- 38 Lee SK, Kim DW, Dhong ES. et al. Facial soft tissue augmentation using autologous fat mixed with stromal vascular fraction. Arch Plast Surg 2012; 39: 534-539
- 39 Koh KS, Oh TS, Kim H. et al. Clinical application of human adipose tissue-derived mesenchymal stem cells in progressive hemifacial atrophy (Parry-Romberg disease) with microfat grafting techniques using 3-dimensional computed tomography and 3-dimensional camera. Ann Plast Surg 2012; 69: 331-337
- 40 Kim M, Kim I, Lee SK. et al. Clinical trial of autologous differentiated adipocytes from stem cells derived from human adipose tissue. Dermatol Surg 2011; 37: 750-759
- 41 Zhu M, Zhou Z, Chen Y. et al. Supplementation of fat grafts with adipose-derived regenerative cells improves long-term graft retention. Ann Plast Surg 2010; 64: 222-228
- 42 Tiryaki T, Findikli N, Tiryaki D. Staged stem cell-enriched tissue (SET) injections for soft tissue augmentation in hostile recipient areas: a preliminary report. Aesthetic Plast Surg 2011; 35: 965-971
- 43 US Food and Drug Administration (FDA). CFR-code of federal regulations title 21. Part 860: medical device classification procedures [Internet]. Silver Spring, MD: FDA; 2013. 2013 Aug 29 Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?cfrpart=25&showfr=1
- 44 Rodriguez RL. FDA: stem cells from your own fat are a drug [Internet]. Lutherville-Timonium, MD: Cosmeticsurg.net; 2013. 2013 Aug 28 Available from: https://www.cosmeticsurg.net/blog/2012/01/11/fda-stem-cells-from-your-own-fat-are-a-drug/
- 45 Pogrel MA, Podlesh S, Anthony JP. et al. A comparison of vascularized and nonvascularized bone grafts for reconstruction of mandibular continuity defects. J Oral Maxillofac Surg 1997; 55: 1200-1206
- 46 Sandor GK, Nish IA, Carmichael RP. Comparison of conventional surgery with motorized trephine in bone harvest from the anterior iliac crest. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 150-155
- 47 Levi B, Glotzbach JP, Wong VW. et al. Stem cells: update and impact on craniofacial surgery. J Craniofac Surg 2012; 23: 319-322
- 48 Wadagaki R, Mizuno D, Yamawaki-Ogata A. et al. Osteogenic induction of bone marrow-derived stromal cells on simvastatin-releasing, biodegradable, nano- to microscale fiber scaffolds. Ann Biomed Eng 2011; 39: 1872-1881
- 49 Cowan CM, Shi YY, Aalami OO. et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004; 22: 560-567
- 50 Haynesworth SE, Goshima J, Goldberg VM. et al. Characterization of cells with osteogenic potential from human marrow. Bone 1992; 13: 81-88
- 51 Lendeckel S, Jodicke A, Christophis P. et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg 2004; 32: 370-373
- 52 Mesimaki K, Lindroos B, Tornwall J. et al. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. Int J Oral Maxillofac Surg 2009; 38: 201-209
- 53 Thesleff T, Lehtimaki K, Niskakangas T. et al. Cranioplasty with adipose-derived stem cells and biomaterial: a novel method for cranial reconstruction. Neurosurgery 2011; 68: 1535-1540
- 54 Warnke PH, Springer IN, Wiltfang J. et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 2004; 364: 766-770
- 55 Warnke PH, Wiltfang J, Springer I. et al. Man as living bioreactor: fate of an exogenously prepared customized tissue-engineered mandible. Biomaterials 2006; 27: 3163-3167
- 56 Sandor GK, Tuovinen VJ, Wolff J. et al. Adipose stem cell tissue-engineered construct used to treat large anterior mandibular defect: a case report and review of the clinical application of good manufacturing practice-level adipose stem cells for bone regeneration. J Oral Maxillofac Surg 2013; 71: 938-950
- 57 Brittberg M, Lindahl A, Nilsson A. et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994; 331: 889-895
- 58 Huselstein C, Li Y, He X. Mesenchymal stem cells for cartilage engineering. Biomed Mater Eng 2012; 22: 69-80
- 59 Diaz-Romero J, Gaillard JP, Grogan SP. et al. Immunophenotypic analysis of human articular chondrocytes: changes in surface markers associated with cell expansion in monolayer culture. J Cell Physiol 2005; 202: 731-742
- 60 Pittenger MF, Mackay AM, Beck SC. et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147
- 61 Nejadnik H, Hui JH, Feng Choong EP. et al. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med 2010; 38: 1110-1116
- 62 Wakitani S, Mitsuoka T, Nakamura N. et al. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant 2004; 13: 595-600
- 63 Wakitani S, Nawata M, Tensho K. et al. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. J Tissue Eng Regen Med 2007; 1: 74-79
- 64 Orozco L, Munar A, Soler R. et al. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation 2013; 95: 1535-1541
- 65 Hennig T, Lorenz H, Thiel A. et al. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol 2007; 211: 682-691
- 66 Estes BT, Diekman BO, Gimble JM. et al. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc 2010; 5: 1294-1311
- 67 Lin Y, Luo E, Chen X. et al. Molecular and cellular characterization during chondrogenic differentiation of adipose tissue-derived stromal cells in vitro and cartilage formation in vivo . J Cell Mol Med 2005; 9: 929-939
- 68 Zhang HN, Li L, Leng P. et al. Uninduced adipose-derived stem cells repair the defect of full-thickness hyaline cartilage. Chin J Traumatol 2009; 12: 92-97
- 69 Bahrani H, Razmkhah M, Ashraf MJ. et al. Differentiation of adipose-derived stem cells into ear auricle cartilage in rabbits. J Laryngol Otol 2012; 126: 770-774
- 70 Rehman J, Traktuev D, Li J. et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004; 109: 1292-1298
- 71 Wang M, Crisostomo PR, Herring C. et al. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 2006; 291: R880-R884
- 72 Ebrahimian TG, Pouzoulet F, Squiban C. et al. Cell therapy based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol 2009; 29: 503-510
- 73 Hong SJ, Jia SX, Xie P. et al. Topically delivered adipose derived stem cells show an activated-fibroblast phenotype and enhance granulation tissue formation in skin wounds. PLoS One 2013; 8: e55640
- 74 Rigotti G, Marchi A, Galie M. et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg 2007; 119: 1409-1422
- 75 Altman AM, Yan Y, Matthias N. et al. IFATS collection: Human adipose-derived stem cells seeded on a silk fibroin-chitosan scaffold enhance wound repair in a murine soft tissue injury model. Stem Cells 2009; 27: 250-258
- 76 Lee HC, An SG, Lee HW. et al. Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study. Circ J 2012; 76: 1750-1760
- 77 Amann B, Ludemann C, Ratei R. et al. [Autologous bone-marrow stem-cell transplantation for induction of arteriogenesis for limb salvage in critical limb ischaemia]. Zentralbl Chir 2009; 134: 298-304
- 78 Tateishi-Yuyama E, Matsubara H, Murohara T. et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427-435
- 79 Esato K, Hamano K, Li TS. et al. Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease. Cell Transplant 2002; 11: 747-752
- 80 Miyamoto K, Nishigami K, Nagaya N. et al. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation 2006; 114: 2679-2684
- 81 Idei N, Soga J, Hata T. et al. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease. Circ Cardiovasc Interv 2011; 4: 15-25
- 82 Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007; 127: 514-525
- 83 Gonzalez MA, Gonzalez-Rey E, Rico L. et al. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 2009; 136: 978-989
- 84 Pinheiro CH, de Queiroz JC, Guimaraes-Ferreira L. et al. Local injections of adipose-derived mesenchymal stem cells modulate inflammation and increase angiogenesis ameliorating the dystrophic phenotype in dystrophin-deficient skeletal muscle. Stem Cell Rev 2012; 8: 363-374
- 85 Yun IS, Jeon YR, Lee WJ. et al. Effect of human adipose derived stem cells on scar formation and remodeling in a pig model: a pilot study. Dermatol Surg 2012; 38: 1678-1688
- 86 Park BS, Jang KA, Sung JH. et al. Adipose-derived stem cells and their secretory factors as a promising therapy for skin aging. Dermatol Surg 2008; 34: 1323-1326
- 87 Kim JH, Jung M, Kim HS. et al. Adipose-derived stem cells as a new therapeutic modality for ageing skin. Exp Dermatol 2011; 20: 383-387
- 88 Kim WS, Park BS, Park SH. et al. Antiwrinkle effect of adipose-derived stem cell: activation of dermal fibroblast by secretory factors. J Dermatol Sci 2009; 53: 96-102
- 89 Kim WS, Park BS, Sung JH. Protective role of adipose-derived stem cells and their soluble factors in photoaging. Arch Dermatol Res 2009; 301: 329-336
- 90 Murakami T, Fujimoto Y, Yasunaga Y. et al. Transplanted neuronal progenitor cells in a peripheral nerve gap promote nerve repair. Brain Res 2003; 974: 17-24
- 91 Cui L, Jiang J, Wei L. et al. Transplantation of embryonic stem cells improves nerve repair and functional recovery after severe sciatic nerve axotomy in rats. Stem Cells 2008; 26: 1356-1365
- 92 Mantovani C, Terenghi G, Shawcross SG. Isolation of adult stem cells and their differentiation to Schwann cells. Methods Mol Biol 2012; 916: 47-57
- 93 Shen CC, Yang YC, Liu BS. Peripheral nerve repair of transplanted undifferentiated adipose tissue-derived stem cells in a biodegradable reinforced nerve conduit. J Biomed Mater Res A 2012; 100: 48-63
- 94 Mohammadi R, Azizi S, Delirezh N. et al. Comparison of beneficial effects of undifferentiated cultured bone marrow stromal cells and omental adipose-derived nucleated cell fractions on sciatic nerve regeneration. Muscle Nerve 2011; 43: 157-163
- 95 Amoh Y, Li L, Katsuoka K. et al. Multipotent nestin-positive, keratin-negative hair-follicle bulge stem cells can form neurons. Proc Natl Acad Sci U S A 2005; 102: 5530-5534
- 96 Amoh Y, Li L, Campillo R. et al. Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves. Proc Natl Acad Sci U S A 2005; 102: 17734-17738
- 97 Walsh SK, Gordon T, Addas BM. et al. Skin-derived precur sor cells enhance peripheral nerve regeneration following chronic denervation. Exp Neurol 2010; 223: 221-228
- 98 Marconi S, Castiglione G, Turano E. et al. Human adipose-derived mesenchymal stem cells systemically injected promote peripheral nerve regeneration in the mouse model of sciatic crush. Tissue Eng Part A 2012; 18: 1264-1272
- 99 Lopatina T, Kalinina N, Karagyaur M. et al. Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de novo. PLoS One 2011; 6: e17899
- 100 Lattanzi W, Geloso MC, Saulnier N. et al. Neurotrophic features of human adipose tissue-derived stromal cells: in vitro and in vivo studies. J Biomed Biotechnol 2011; 2011: 468705